Valuation Johnson & Johnson

Equities

Real-time Estimate Cboe BZX Other stock markets 18:18:34 16/03/2026 GMT			5-day change	1st Jan Change
242.91 ^USD	+0.58%		+0.11%	+17.35%

12:37pm	Monte Rosa Therapeutics Announces Clinical Supply Agreement to Support Phase 2 Trial Evaluating MRT-2359 in Combination with Apalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer	CI
12:36pm	Nasus Pharma Ltd Announces Positive Top Line Data from Phase 2 Clinical Study of NS002	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	448,463	461,875	376,932	349,226	500,242	581,728	-	-
Change	-	2.99%	-18.39%	-7.35%	43.24%	16.29%	-	-
Enterprise Value (EV) ¹	450,606	478,015	383,337	361,338	528,042	599,715	587,789	592,128
Change	-	6.08%	-19.81%	-5.74%	46.14%	13.57%	-1.99%	0.74%
P/E ratio	21.8x	26.2x	11.4x	25.1x	18.8x	25.6x	23.7x	23.1x
PBR	6.05x	6.13x	5.83x	4.88x	6.14x	6.65x	5.9x	5.4x
PEG	-	-1.9x	0x	-0.4x	0.2x	-1.8x	2.96x	9.22x
Capitalization / Revenue	4.78x	4.86x	4.43x	3.93x	5.31x	5.78x	5.48x	5.17x
EV / Revenue	4.81x	5.03x	4.5x	4.07x	5.61x	5.96x	5.53x	5.26x
EV / EBITDA	12.3x	14.6x	12.6x	12.3x	15.9x	16.2x	14.9x	14x
EV / EBIT	15.4x	16x	14x	13.7x	17.4x	17.9x	16.3x	15x
EV / FCF	22.8x	27.8x	21x	18.2x	26.8x	23.9x	22.3x	20.4x
FCF Yield	4.38%	3.6%	4.76%	5.49%	3.73%	4.19%	4.48%	4.9%
Dividend per Share ²	4.19	4.45	4.7	4.91	5.14	5.299	5.598	5.737
Rate of return	2.46%	2.52%	3%	3.39%	2.48%	2.19%	2.32%	2.38%
EPS ²	7.81	6.73	13.72	5.79	11.03	9.424	10.18	10.44
Distribution rate	53.6%	66.1%	34.3%	84.8%	46.6%	56.2%	55%	55%
Net sales ¹	93,775	94,943	85,159	88,821	94,193	100,589	106,216	112,524
EBITDA ¹	36,634	32,630	30,414	29,288	33,261	36,942	39,370	42,312
EBIT ¹	29,244	29,965	27,460	26,466	30,358	33,444	36,119	39,381
Net income ¹	20,878	17,941	35,153	14,066	26,804	22,241	23,934	25,375
Net Debt ¹	2,143	16,140	6,405	12,112	27,800	17,987	6,061	10,400
Reference price ²	170.35	176.66	156.58	145.05	207.63	241.52	241.52	241.52
Nbr of stocks (in thousands)	2,632,597	2,614,484	2,407,279	2,407,623	2,409,295	2,408,613	-	-
Announcement Date	25/01/22	24/01/23	23/01/24	22/01/25	21/01/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
JOHNSON & JOHNSON	25.63x	5.96x	16.23x	2.19%	582B
ELI LILLY AND COMPANY	28.95x	10.91x	21.91x	0.67%	880B
ABBVIE INC.	24x	6.55x	13.15x	3.16%	388B
ROCHE HOLDING AG	17.32x	4.22x	10.43x	3.13%	324B
ASTRAZENECA PLC	23.94x	4.98x	13.83x	1.75%	295B
NOVARTIS AG	20.93x	5.64x	13.96x	2.87%	293B
MERCK & CO., INC.	27.02x	4.74x	14.82x	2.92%	286B
AMGEN INC.	24.64x	6.26x	11.14x	2.74%	197B
GILEAD SCIENCES, INC.	20.1x	6.12x	11.06x	2.25%	180B
NOVO NORDISK A/S	11.62x	4.21x	8.75x	4.33%	168B
Average	22.41x	5.96x	13.53x	2.6%	359.42B
Weighted average by Cap.	24.12x	6.82x	15.38x	2.22%